Monsanto, Bayer, Novozymes and Syngenta-backed agricultural technology developer AgBiome increased its overall funding to $230m in the round.

AgBiome, a US-based agricultural technology developer backed by corporates Monsanto, Bayer, Novozymes and Syngenta, collected $116m in series D funding yesterday. The round was co-led by venture capital firm Novalis LifeSciences and investment firm Blue Horizon while undisclosed new and existing investors also contributed to the financing. AgBiome has developed the Genesis platform, which is…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.